Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avatrombopag Once-daily in Japanese Chronic Liver Disease With Thrombocytopenia
jRCT2080222686Phase 2
- Sponsor
- Eisai Co., Ltd.
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of avatrombopag in chronic liver disease (CLD) and Thrombocytopenia (4 arms), sponsored by Eisai Co., Ltd.
02
Drugs
avatrombopag
03
Conditions
chronic liver disease (CLD)Thrombocytopenia
Beyond the preview
Go deeper on jRCT2080222686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222686.